Paid Clinical Trials in St. Louis Missouri

Candace Kastanis

Written by Candace Kastanis

Chemistry B.S. | UC Davis | Clinical Lab Technician

Updated & Fact Checked 7/30/26

St. Louis Clinical Research for Compensation

Paid Clinical Trials in Kansas City

St. Louis punches above its weight in medical research. As of July 2026, 1,346 studies are actively recruiting in the city, according to ClinicalTrials.gov, and Washington University School of Medicine accounts for the largest share by a wide margin.

As of 2022, the population of St. Louis is reckoned at 298,034, but that excludes the surrounding Combined Statistical Area (CSA), which increases the population to about 2,909,003. These numbers are important to understand, as finding Clinical Research Organizations, or CROs, is best done in areas of high population. The experts say 1 in 200 citizens across the US need to be involved in clinical research throughout the year to maintain forward scientific advances. For St Louis and the adjacent CSA, that means you’ve got between 1,490 and 14,545+ individual opportunities in this area.

Currently, there are about 143 CROs providing paid trial opportunities in the CSA including and surrounding St. Louis. This means between 10 to 101 opportunities for each CRO, depending on whether or not you expand your search beyond St. Louis proper into the surrounding CSA or not. We’re going to explore some further data here to help you narrow down where your opportunities may be found in the local area.

Quick Facts: Paid Clinical Trials in St. Louis

  • Actively recruiting studies (July 2026): 1,346 in St. Louis (ClinicalTrials.gov)
  • Typical compensation: $50–$100 per completed outpatient visit; residential Phase 1 studies pay more (see highest paid clinical trials)
  • Cost to participate: $0 — study care and visits are covered by the sponsor
  • Worth knowing: Siteman Cancer Center operates satellite sites around the metro, so some trials run closer to home than the main campus
  • Statewide options: see paid clinical trials in Missouri

Where St. Louis trials actually run

We sampled recruiting St. Louis studies on ClinicalTrials.gov in July 2026. The sites running the most trials:

Research siteTrials sampled
Washington University School of Medicine311
Mercy Hospital St. Louis52
Mercy Hospital South51
Missouri Baptist Medical Center49
Siteman Cancer Center – South County45

Washington University and its Siteman Cancer Center dominate, but Siteman runs satellite locations across the metro, so many studies are available without traveling to the main medical campus.

Demographic Data Reveals Availability in St. Louis

Just in St. Louis proper, you’re most likely to find paid clinical trials nearby for healthy volunteers that track the demographic availability of potential participants. In St. Louis, approximately 46.44% of the population is white, 45.66% of the population is black or of African descent, Asians are 3.37% of the population, and those with 2 or more ethnicities in their background are approximately 3.10% of the population. The median age of the city is 36, women constitute 51.53% of the population, and men comprise 48.47% of the population.

Consent for Use of Stored Patient Specimens for Future Testing
Recruiting
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.
Gender:
ALL
Ages:
All
Trial Updated:
09/20/2024
Locations: Univ of Southern California / LA County USC Med Ctr, Los Angeles, California
Conditions: HIV Infections
Mucopolysaccharidosis I (MPS I) Registry
Recruiting
The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients receiving enzyme replacement therapy, such as Aldurazyme (Recombinant Human Alpha-L-Iduronidase), or other treatment modalities. The objectives of the Registry are: * To evaluate the lon... Read More
Gender:
ALL
Ages:
All
Trial Updated:
11/19/2024
Locations: Phoenix Children's Hospital- Site Number : 840003, Phoenix, Arizona
Conditions: Mucopolysaccharidosis I (MPS I)
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
Recruiting
The main purpose of this study is to compare genetic markers present on tumor cells before and after chemotherapy.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/17/2025
Locations: Washington University School of Medicine, Saint Louis, Missouri
Conditions: Breast Neoplasms
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Recruiting
The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient for engraftment of donor hematopoietic cells. It is also to determine major toxicities from these conditioning regimens, within the first 100 days after transplantation.
Gender:
ALL
Ages:
20 years and below
Trial Updated:
07/19/2024
Locations: Phoenix Children's Hospital, Phoenix, Arizona +1 locations
Conditions: Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies, Non-malignant Disorders
ATI-450 in Combination With Paclitaxel or Capecitabine in Patients With Hormone Receptor-positive and HER2 Negative Metastatic Breast Cancer With Bone Metastasis
Recruiting
This is a dose-escalating phase I using a rolling 6 design and randomized phase II study of ATI-450 in combination with chemotherapy testing the hypothesis that the combination of chemotherapy (paclitaxel or capecitabine) and ATI-450 will improve progression-free survival and reduce bone turnover, improve patient bone density, improve patient quality of life, and improve clinical efficacy.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/21/2020
Locations: Kansas University, Kansas City, Kansas
Conditions: Breast Cancer, Cancer of Breast
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
The present study D5272C00001 (Legacy # 3151-201-008) seeks to evaluate the efficacy and safety of brazikumab versus placebo in patients with moderately to severely active UC and will include assessments of clinical responses as demonstrated by improvement of symptoms and of colonic mucosal appearance as observed on endoscopy.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/19/2021
Locations: Research Site, Tucson, Arizona
Conditions: Ulcerative Colitis
Study to Evaluate The Safety and Efficacy of Balovaptan in Patients With Acute Ischemic Stroke at High Risk of Developing Malignant Brain Edema
Recruiting
This study is designed to evaluate the safety, efficacy, and pharmacokinetics of balovaptan compared with placebo in participants with acute ischemic stroke (AIS) at risk of developing malignant cerebral edema (MCE)
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
04/04/2022
Locations: University of Alabama At Birmingham, Birmingham, Alabama
Conditions: Acute Ischemic Stroke
Peer Caregiver Navigation for Family Caregivers in Oncology
Recruiting
This clinical trial assesses the feasibility and acceptability of the psychosocial intervention peer caregiver navigation (PCN) in an outpatient oncology setting. PCN is a peer mentoring service designed to help family caregivers navigate and mitigate the distress of caregiving by enhancing and promoting the emotional and behavioral coping efforts of the caregiver.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/12/2022
Locations: Washington University School of Medicine, Saint Louis, Missouri
Conditions: Caregiver Burden, Metastatic Cancer
CERENOVUS Neurothrombectomy Devices Registry
Recruiting
A post-market registry evaluating the EmboTrap® Revascularization Device and CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/19/2022
Locations: The University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Cerebral Stroke
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
Recruiting
The purpose of this study is to compare the efficacy, safety, and tolerability of ide-cel with lenalidomide (LEN) maintenance to that of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response post autologous stem cell transplantation (ASCT).
Gender:
All
Ages:
18 years and above
Trial Updated:
05/01/2024
Locations: Banner MD Anderson Cancer Center, Gilbert, Arizona +1 locations
Conditions: Multiple Myeloma

Interpreting St. Louis Demographic Information to Identify Paid Trials

In order to narrow things down further, you’ve got to parse the data. Essentially, the preponderance of paid clinical trials for healthy volunteers in St. Louis will be for adults in their late thirties, primarily female, who have a strong ethnic component to their background. There are opportunities for non-ethnic individuals, and most studies require diversity for best results.


St. Louis CROs Healthy Participants Might Explore For Opportunities

To figure out where you should seek healthy volunteer paid clinical trials locally in St. Louis, we’ve put together several options to choose from that are located in varying areas of the city:


Medical Trends in St. Louis That Have Influenced the Science

Beyond the deep historicity of St. Louis proper, the city has been at the ground floor of many medical discoveries over the years. If you’re involved in paid clinical trials locally, you could contribute to such discoveries, carving out your own personal niche in world history. Here are three areas of innovation and discovery in medicine which St. Louis is presently known for:


St. Louis Paid Clinical Trial FAQs

  • How much do paid clinical trials pay in St. Louis?

    Most outpatient studies pay $50–$100 per completed visit, plus travel reimbursement. The exact amount appears in the consent form before you enroll.

  • Where are most St. Louis trials located?

    The Washington University Medical Campus in the Central West End holds the largest concentration, including Barnes-Jewish Hospital and Siteman Cancer Center. Mercy, Missouri Baptist, and SSM Health run additional studies, and Siteman has satellite sites in South County, West County, and St. Peters.

  • Can I join a Washington University study if I am not a patient there?

    Yes. Many studies recruit from the general public, including healthy volunteers. Check the eligibility criteria on the study record and contact the coordinator directly.

St. Louis CRO Trial Opportunities Healthy Volunteers Might Consider

At the end of the day, if you’re seeking paid opportunities in the area for clinical studies, you have over a thousand options in St. Louis proper, and several thousand once you get out of the city limits. You can be part of history, advance medical science, and make a little money simultaneously.